|
Volumn 4, Issue 1, 2006, Pages 15-22
|
America's generic pharmaceutical industry: Opportunities and challenges in 2006 and beyond
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
GENERIC DRUG;
RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;
ALERTNESS;
ARTICLE;
CANCER THERAPY;
COMMERCIAL PHENOMENA;
COMPETITION;
COST CONTROL;
DRUG APPROVAL;
DRUG COST;
DRUG INDUSTRY;
DRUG MARKETING;
FINANCIAL MANAGEMENT;
HEALTH CARE COST;
HUMAN;
PRESCRIPTION;
UNITED STATES;
|
EID: 33846877377
PISSN: 17411343
EISSN: 17417090
Source Type: Journal
DOI: 10.1057/palgrave.jgm.4950047 Document Type: Article |
Times cited : (5)
|
References (0)
|